| Final diagnosis (% of total) | Sensitivity | Specificity | PPV | NPV | Accuracy |
| Overall | 76.1% | 88.1% | 95.6% | 52.1% | 78.8% |
| Lymphoma (3.8%) | 53.8% | 100% | 100% | 96.6% | 96.2% |
| Sarcoidosis (14.1%) | 60.0% | 91.8% | 53.6% | 93.6% | 87.5% |
| Tuberculosis (17.8%) | 76.5% | 100% | 100% | 94.9% | 96.5% |
| Metastatic carcinoma (21.1%) | 76.9% | 100% | 100% | 94.2% | 95.1% |
| SCLC (12.4%) | 100% | 100% | 100% | 100% | 100% |